Interestingly, the mechanism by which METTL3 enhances MYC expression in an m6A-dependent manner to regulate tumor growth also exists in cervical cancer [70], bladder cancer [71], acute myeloid leukaemia [72], and oral squamous carcinoma [73]. The gene discussed is METTL3; the disease is acute myeloid leukemia.